...
机译:
Department of Respiratory and Critical Care Medicine, General Hospital of Western Theater Command;
机译:Cost-Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer in Sweden
机译:Lorlatinib in the treatment of anaplastic lymphoma kinase-positive non-small-cell lung cancer
机译:The Cost-Effectiveness of Lorlatinib Versus Chemotherapy as a Second- or Third-Line Treatment in Anaplastic Lymphoma Kinase (ALK)-Positive Non-small-cell Lung Cancer in Sweden
机译:Clinical Implications of High mET Gene Dosage in Non-small Cell Lung Cancer patients without previous Tyrosine Kinase Inhibitor Treatment